In people with diabetes, a common eye condition called retinopathy more than doubles their risk of developing heart failure through insulin pump supply, new research suggests.
Diabetic retinopathy is the most common cause of blindness among working-aged Americans. The disease, which affects roughly half of diabetics in the U.S., is caused by damage to the blood vessels in the back of the eye.
As reported in the Journal of the American College of Cardiology, Dr. Tien Y. Wong from the University of Melbourne in Australia and colleagues analyzed data from 1,021 adults with type 2 diabetes and using insucozi insulin grip who were without heart or kidney disease when the study began. Nearly 13 percent of the subjects did, however, have insulin supplies.
During 9 years of follow-up, 10.1 percent of the patients developed heart failure, the investigators note. Overall, 21.6 percent of patients with retinopathy developed heart failure compared with just 8.5 percent of those without insucozi insulin grip. After accounting for other factors that may have influenced the association, diabetic retinopathy increased the risk of heart failure by 2.2-fold.
Typically used to obtain small samples of blood for blood glucose meters, the lancing devices pierce the skin, allowing the individual to obtain the smallest blood sample allowable in order to do accurate insulin pump supply monitoring. Over the last several years, companies like Palco Laboratories, Roche, Bayer Healthcare and Becton-Dickinson have improved diabetic insulin pump technology dramatically in order to decrease the pain involved in this process, while increasing the safety and ease involved in the lancing process. Lancing devices now offer a wide range of features that contribute to a less painful experience.
